New guidelines on cervical cancer screening: More than just the end of annual pap testing

Journal of Lower Genital Tract Disease

Volumn 16, Issue 3, 2012, Pages 172-174

  Massad, L Stewart ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; VIRUS VACCINE;

CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; EVIDENCE BASED PRACTICE; FALSE POSITIVE RESULT; INFORMATION RETRIEVAL; MEDICAL SOCIETY; PAPANICOLAOU TEST; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; SCIENTIFIC LITERATURE; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VACCINATION; VIRUS CARCINOGENESIS; VIRUS INFECTION; WART VIRUS;

COLPOSCOPY; EARLY DETECTION OF CANCER; FEMALE; FORECASTING; HUMANS; MASS SCREENING; PATHOLOGY, MOLECULAR; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL; UNITED STATES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84863566369     PISSN: 10892591     EISSN: 15260976     Source Type: Journal    
DOI: 10.1097/LGT.0b013e31824bc178     Document Type: Review

References (8)

1. Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. J Lower Genital Tract Dis 2012;16:xxxYxxx.
2. Roland KB, Soman A, Benard VB, Saraiya M. Human papillomavirus and Papanicolaou tests screening interval recommendations in the United States. Am J Obstet Gynecol 2011;205:447.e1-8.
3. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-6.
4. Saraiya M, Zahava Berkowitz Z, Robin K, Yabroff KR, Wideroff L, Kobrin S, et al. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: What screening intervals are physicians recommending? Arch Intern Med 2010;170:977-86.
5. Bruinsma FJ, Quinn MA. The risk of preterm birth following treatment for precancerous changes in the cervix: A systematic review and meta-Analysis. BJOG 2011;118:1031-41.
6. Whitlock EP, Vesco KK, Eder M, Lin JS, Senger CA, Burda BU. Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: A systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2011;155: 687-97.
7. Vesco KK, Whitlock EP, Eder M, Burda BU, Senger CA, Lutz K. Risk factors and other epidemiologic considerations for cervical cancer screening: A narrative review for the U.S. Preventive Services Task Force. Ann Intern Med 2011;155: 698-705.
8. Brawley O, Byers T, Chen A, Pignone M, Ransohoff D, Schenk M, et al. New American Cancer Society process for creating trustworthy cancer screening guidelines. JAMA 2011; 306:2495-9.